1. Home
  2. JBIO vs VMD Comparison

JBIO vs VMD Comparison

Compare JBIO & VMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JBIO
  • VMD
  • Stock Information
  • Founded
  • JBIO 2024
  • VMD 2006
  • Country
  • JBIO United States
  • VMD United States
  • Employees
  • JBIO N/A
  • VMD N/A
  • Industry
  • JBIO
  • VMD
  • Sector
  • JBIO
  • VMD
  • Exchange
  • JBIO NYSE
  • VMD Nasdaq
  • Market Cap
  • JBIO 290.1M
  • VMD 273.5M
  • IPO Year
  • JBIO N/A
  • VMD N/A
  • Fundamental
  • Price
  • JBIO $8.28
  • VMD $6.12
  • Analyst Decision
  • JBIO Strong Buy
  • VMD
  • Analyst Count
  • JBIO 2
  • VMD 0
  • Target Price
  • JBIO $15.50
  • VMD N/A
  • AVG Volume (30 Days)
  • JBIO 397.1K
  • VMD 227.1K
  • Earning Date
  • JBIO 08-05-2025
  • VMD 08-06-2025
  • Dividend Yield
  • JBIO N/A
  • VMD N/A
  • EPS Growth
  • JBIO N/A
  • VMD 19.95
  • EPS
  • JBIO N/A
  • VMD 0.30
  • Revenue
  • JBIO N/A
  • VMD $232,793,000.00
  • Revenue This Year
  • JBIO N/A
  • VMD $17.35
  • Revenue Next Year
  • JBIO N/A
  • VMD $12.87
  • P/E Ratio
  • JBIO N/A
  • VMD $20.50
  • Revenue Growth
  • JBIO N/A
  • VMD 19.97
  • 52 Week Low
  • JBIO $1.61
  • VMD $6.11
  • 52 Week High
  • JBIO $13.50
  • VMD $9.81
  • Technical
  • Relative Strength Index (RSI)
  • JBIO N/A
  • VMD 28.58
  • Support Level
  • JBIO N/A
  • VMD $6.59
  • Resistance Level
  • JBIO N/A
  • VMD $6.76
  • Average True Range (ATR)
  • JBIO 0.00
  • VMD 0.18
  • MACD
  • JBIO 0.00
  • VMD -0.07
  • Stochastic Oscillator
  • JBIO 0.00
  • VMD 2.06

About JBIO JADE BIOSCIENCES INC

Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases. Its asset, JADE-001, will target the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for immunoglobulin A (IgA) nephropathy, with Investigational New Drug Application-enabling studies underway and initiation of a first-in-human trial. Jade's pipeline also includes two undisclosed optimized antibody discovery programs, JADE-002 and JADE-003, currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount.

About VMD Viemed Healthcare Inc.

Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.

Share on Social Networks: